GlassScriptPhysician profile
Christian Massier
NPI 1700080140
$3,489.53
in general payments reported to CMS, 2019-2025
20 companies · $1,037 in 2025
The $1,037 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $64.25 · 2021: $367 · 2022: $156 · 2023: $952 · 2024: $746 · 2025: $1,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,285 · Consulting Fee: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,284.63 |
| Consulting Fee | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $517.16 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Aroa Biosurgery Incorporated | $516.52 | 2023-2025 | |
| Applied Medical Resources Corporation | $375.00 | 2023 | |
| Innovation Technologies INC | $297.63 | 2023-2025 | Irrisept |
| Dilon Technologies, INC. | $267.51 | 2023-2024 | Hemoblast Bellows |
| Kerecis Limited | $175.05 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Misonix INC | $172.53 | 2021 | |
| Stryker Corporation | $160.00 | 2025 | Spy-Phi System |
| Ethicon US, LLC | $150.83 | 2020-2025 | Contour |
| Pacira Pharmaceuticals Incorporated | $121.75 | 2021 | |
| Medtronic, INC. | $121.75 | 2023-2025 | Endo Clip III, Merocel, Eea |
| Teleflex LLC | $108.03 | 2025 | Titan Sgs Bailout Chuck |
| Ekos Corporation | $99.10 | 2019 | |
| W. L. Gore & Associates, INC. | $98.46 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Intuitive Surgical, INC. | $83.54 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $69.01 | 2019 | |
| Solventum Corporation | $68.56 | 2025 | V.A.C. Veraflo |
| Takeda Pharmaceuticals U.S.A., INC. | $30.62 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $29.48 | 2024-2025 | |
| Kci USA, INC. | $27.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Massier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.